Skip to main content
Skip to main content
DXBRF logo

BellRock Brands Inc. (DXBRF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.00005 $0.00 (0.00%) |CouncilSplit View · 53 · B
Vol: 100| 52-wk range: $0.000001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

BellRock Brands Inc. (DXBRF) trades at $0.00005. BellRock Brands Inc. develops, markets, and sells cannabis products across the United States, Canada, and internationally, offering a diverse portfolio of infused products and branded hemp items. Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026
BellRock Brands Inc. develops, markets, and sells cannabis products across the United States, Canada, and internationally, offering a diverse portfolio of infused products and branded hemp items. As a subsidiary of West 4th Holdings, LLC, the company focuses on expanding its brand presence and product offerings in the evolving cannabis market.

Analyst Coverage for DXBRF: DXBRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DXBRF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the DXBRF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Council Score · Weighted Average of 3 Disciplines
Split View 53/100 · B

DXBRF: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

BellRock Brands Inc. (DXBRF) Healthcare & Pipeline Overview

CEOSat Joshi
Employees91
HeadquartersDenver, US
IPO Year2020

BellRock Brands Inc. operates in the cannabis industry, offering a diverse range of infused adult-use and hemp-based products. With a portfolio of recognized brands and a focus on innovation, the company aims to capture market share in the competitive cannabis landscape, while navigating regulatory complexities and evolving consumer preferences.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for DXBRF?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

BellRock Brands Inc. operates in the high-growth cannabis market, but profitability is a concern with a negative P/E ratio and a profit margin of -181.5%. The company's gross margin of 36.2% indicates some pricing power, but significant operational improvements are needed to achieve profitability. Growth catalysts include expanding product lines and entering new geographic markets. BellRock's diverse brand portfolio and focus on product innovation could drive revenue growth. However, investors should closely monitor the company's ability to manage costs and achieve profitability. The company's status as a subsidiary of West 4th Holdings, LLC adds another layer of complexity, as its strategic decisions may be influenced by its parent company. The negative beta of -134.88 suggests the stock moves inversely to the market, potentially offering diversification benefits, but also indicating unique risk factors.

Based on FMP financials and quantitative analysis

DXBRF Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.

  • Negative P/E ratio of -0.00 reflects current unprofitability, requiring a focus on future earnings potential.
  • Profit margin of -181.5% highlights the need for significant cost management and operational efficiency improvements.
  • Gross margin of 36.2% suggests potential for profitability if operating expenses are better controlled.
  • Negative beta of -134.88 indicates the stock's price movements are inversely correlated with the market.

Who Are DXBRF's Competitors?

DXBRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CXXIF C21 Investments Inc. $0.26 -0.11% $31.4M
LEEEF Leef Brands Inc. $0.19 +1.84% $38.8M
MILFF 1CM Inc. $0.22 0.00% $26.3M
AVCNF Avicanna Inc. $0.08 0.00% $10.6M 529-signal
PLNH Planet 13 Holdings Inc. $0.13 -7.14% $42.7M 429-signal
DBCCF Decibel Cannabis Company Inc. $1.27 -3.39% $49.0M 459-signal
ZYBT Zhengye Biotechnology Holding Limited $1.59 +1.27% $75.4M 465-pillar
CWBHF Charlotte's Web Holdings, Inc. $0.35 +6.23% $93.9M 519-signal

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are DXBRF's Key Strengths?

Diverse brand portfolio with established brands.

  • Wide range of cannabis and hemp-infused products.
  • International presence in the United States, Canada, and internationally.
  • Focus on product innovation and development.

What Are DXBRF's Weaknesses?

Negative profit margin and P/E ratio indicate financial challenges.

  • Reliance on parent company West 4th Holdings, LLC.
  • Limited market capitalization may restrict access to capital.
  • Exposure to evolving regulatory landscape.

What Could Drive DXBRF Stock Higher?

Expansion into new geographic markets as cannabis legalization progresses.

  • Product innovation and development to meet evolving consumer preferences.
  • Strategic partnerships and acquisitions to expand market reach.
  • Growth in the hemp-infused product market.
  • Brand building and marketing efforts to increase brand awareness.

What Are the Key Risks for DXBRF?

Financial-distress signal — its Altman Z-Score of -12.08 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from established and emerging cannabis companies.
  • Evolving regulatory landscape and potential changes in cannabis laws.
  • Fluctuations in cannabis prices and consumer demand.
  • Potential for negative publicity or product recalls.
  • Financial challenges and operational inefficiencies.

What Are the Growth Opportunities for DXBRF?

  • Expansion into New Geographic Markets: BellRock Brands has the opportunity to expand its presence in emerging cannabis markets, both domestically and internationally. As more countries and states legalize cannabis, the company can leverage its existing brands and product portfolio to enter these new markets. This expansion could significantly increase revenue and market share, provided the company navigates the regulatory landscape effectively. The global cannabis market is projected to reach $55 billion by 2026, offering substantial growth potential.
  • Product Innovation and Development: BellRock Brands can drive growth by continuously innovating and developing new cannabis-infused products. This includes exploring new formulations, delivery methods, and product categories to meet evolving consumer preferences. By staying ahead of the curve in product innovation, the company can attract new customers and retain existing ones. The market for cannabis-infused products is expected to grow rapidly, driven by increasing consumer demand for novel and convenient consumption options.
  • Strategic Partnerships and Acquisitions: BellRock Brands can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, or retailers to enhance its product offerings and distribution channels. Acquisitions can provide access to new brands, technologies, or geographic markets, accelerating the company's growth. The cannabis industry is consolidating, creating opportunities for strategic alliances and acquisitions.
  • Development of Branded Hemp-Infused Products: BellRock Brands can capitalize on the growing market for hemp-infused products by expanding its branded offerings for humans and pets. Hemp-derived CBD products are gaining popularity due to their perceived health benefits and lack of psychoactive effects. By developing high-quality, branded hemp products, the company can tap into this growing market segment. The global CBD market is projected to reach $22 billion by 2027, offering significant growth potential.
  • Focus on Brand Building and Marketing: BellRock Brands can invest in brand building and marketing to increase brand awareness and customer loyalty. This includes developing targeted marketing campaigns, leveraging social media, and engaging with consumers through educational content. By building strong brands, the company can differentiate itself from competitors and command premium pricing. Brand building is crucial in the cannabis industry, where consumers are increasingly seeking trusted and reputable brands.

What Are DXBRF's Competitive Advantages?

  • Established Brand Portfolio: BellRock Brands has a portfolio of well-known brands, including Mary's Medicinals and Dixie, which provide a competitive advantage.
  • Product Diversification: The company offers a wide range of cannabis and hemp-infused products, catering to various consumer preferences.
  • Distribution Network: BellRock Brands has established distribution channels in the United States, Canada, and internationally.
  • Focus on Innovation: The company invests in product development and innovation to stay ahead of the competition.

What Does DXBRF Do?

BellRock Brands Inc., formerly known as Dixie Brands Inc., was rebranded in October 2020 and is headquartered in Denver, Colorado. The company develops, markets, and sells a wide array of cannabis products, including topicals, confections, edibles, beverages, and concentrates. These products cater to the adult-use market and include transdermal patches, tinctures, capsules, lotions, creams, vapes, and cosmetic serums. BellRock Brands also offers hemp-infused products for both humans and pets. The company's brand portfolio includes Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. These brands target various consumer segments and preferences within the cannabis and hemp markets. BellRock Brands operates in the United States, Canada, and internationally, seeking to establish a global presence in the cannabis industry. As of October 10, 2022, BellRock Brands Inc. operates as a subsidiary of West 4th Holdings, LLC, which may influence its strategic direction and resource allocation. BellRock Brands focuses on innovation and product development to stay competitive in the rapidly evolving cannabis market. The company's diverse product range and brand portfolio allow it to cater to a broad spectrum of consumer needs and preferences. The company's evolution from Dixie Brands to BellRock Brands reflects its strategic shift and commitment to growth within the cannabis industry.

What Products and Services Does DXBRF Offer?

  • Develops and markets cannabis-infused adult-use topicals.
  • Offers cannabis-infused confections, edibles, and beverages.
  • Produces cannabis concentrates and transdermal patches.
  • Provides tinctures, capsules, lotions, and creams.
  • Sells vapes and cosmetic serums.
  • Offers branded hemp-infused products for humans and pets.
  • Operates in the United States, Canada, and internationally.

How Does DXBRF Make Money?

  • Develops and manufactures a range of cannabis-infused products.
  • Markets and sells products through various distribution channels.
  • Generates revenue through the sale of cannabis and hemp-infused products.
  • Focuses on brand building and product innovation to drive sales.

What Industry Does DXBRF Operate In?

BellRock Brands Inc. operates within the rapidly expanding cannabis industry, which is experiencing significant growth due to increasing legalization and changing consumer attitudes. The market includes numerous competitors, ranging from large, established companies to smaller, niche players. BellRock Brands competes with companies like CXXIF (Columbia Care Inc.), ELIXF (Elixir Games), FLOOF (Fluffco), LEEEF (LiefMed Inc.), and MILFF (Milestone Brands Inc.). The industry is characterized by evolving regulations, intense competition, and the need for continuous innovation to meet consumer demand. BellRock Brands aims to differentiate itself through its diverse brand portfolio and product offerings.

Who Are DXBRF's Key Customers?

  • Adult-use cannabis consumers seeking recreational products.
  • Consumers seeking cannabis-infused topicals, edibles, and beverages.
  • Individuals looking for hemp-infused products for health and wellness.
  • Pet owners seeking hemp-infused products for their pets.
Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 56
2026-08-26 56
2026-08-29 56
2026-09-01 56
2026-09-04 56
2026-09-07 56
2026-09-10 56

What changed?

The score has stayed at 56.

Over the same 18 days the stock moved +0.0%.

Company Profile

BellRock Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO Sat Joshi. DXBRF has traded publicly since 2020.

F-Score 2/9

Financial Health

BellRock Brands Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -12.08 places it in the distress zone, a signal of elevated financial risk.

DXBRF Financials

Fundamental Snapshot

Return on Equity (TTM)
-266.8%
Current Ratio
0.5

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Diverse brand portfolio with established brands.
  • Wide range of cannabis and hemp-infused products.
  • International presence in the United States, Canada, and internationally.
  • Focus on product innovation and development.

Bear Case

  • Negative profit margin and P/E ratio indicate financial challenges.
  • Reliance on parent company West 4th Holdings, LLC.
  • Limited market capitalization may restrict access to capital.
  • Exposure to evolving regulatory landscape.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

DXBRF Latest News

DXBRF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DXBRF.

Price Targets

Wall Street price target analysis for DXBRF.

DXBRF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DXBRF; grades run from A+ (80-100) to F (below 30).

Leadership: Sat Joshi

CEO

Sat Joshi serves as the CEO of BellRock Brands Inc., leading the company's strategic direction and operations. His background includes experience in managing and scaling businesses within the consumer packaged goods and cannabis industries. He has a proven track record of driving revenue growth and improving operational efficiency. Joshi's expertise spans across various functional areas, including marketing, sales, and product development. He is responsible for overseeing the company's brand portfolio and expanding its market presence.

Track Record: Under Sat Joshi's leadership, BellRock Brands has focused on expanding its product offerings and entering new geographic markets. He has overseen the rebranding of the company from Dixie Brands to BellRock Brands, reflecting a strategic shift towards a broader range of cannabis and hemp-infused products. Joshi has also focused on improving the company's financial performance and operational efficiency. Key milestones include launching new product lines and expanding distribution channels.

DXBRF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that BellRock Brands Inc. may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same rigorous listing requirements, which can increase investment risk.

  • OTC Tier: OTC Other
Liquidity: As an OTC Other stock, DXBRF likely experiences low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. The limited liquidity can result in significant price fluctuations and increased transaction costs. Investors may encounter challenges in executing large trades without significantly impacting the stock price. The illiquidity of the stock increases the risk of holding shares.
OTC Risk Factors:
  • Limited Financial Disclosure: The lack of readily available financial information increases the risk of investing in the company.
  • Low Liquidity: The low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
  • Regulatory Uncertainty: The cannabis industry is subject to evolving regulations, which can impact the company's operations and financial performance.
  • Operational Challenges: The company's negative profit margin and P/E ratio indicate financial challenges and operational inefficiencies.
  • Dependence on Parent Company: The company's status as a subsidiary of West 4th Holdings, LLC adds another layer of complexity and potential risk.
Due Diligence Checklist:
  • Verify the company's financial statements and audit reports.
  • Assess the company's management team and their experience.
  • Evaluate the company's competitive position and market share.
  • Review the company's regulatory filings and compliance status.
  • Analyze the company's capital structure and debt levels.
  • Investigate the company's ownership structure and related party transactions.
  • Monitor the company's news and press releases for any material developments.
Legitimacy Signals:
  • Established Brand Portfolio: BellRock Brands has a portfolio of well-known brands, including Mary's Medicinals and Dixie.
  • Operational History: The company has been operating in the cannabis industry for several years.
  • Product Diversification: The company offers a wide range of cannabis and hemp-infused products.
  • International Presence: The company operates in the United States, Canada, and internationally.
  • Experienced Management Team: The company is led by an experienced management team with a track record in the cannabis industry.

DXBRF Healthcare Stock FAQ

Is DXBRF a good stock?

Stock Expert AI does not rate DXBRF buy, sell or hold. BellRock Brands Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about DXBRF stock?

As of March 16, 2026, there is no readily available analyst consensus on DXBRF stock due to its OTC listing and limited coverage.

What are the key factors to evaluate for DXBRF?

Evaluate DXBRF on fundamentals, analyst consensus, and risk factors. BellRock Brands Inc. operates in the high-growth cannabis market, but profitability is a concern with a negative P/E ratio and a profit margin of -181.5%. Not financial advice.

How frequently does DXBRF data refresh on this page?

DXBRF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven DXBRF's recent stock price performance?

BellRock Brands Inc. (DXBRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse brand portfolio with established brands. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DXBRF overvalued or undervalued right now?

BellRock Brands Inc. (DXBRF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of DXBRF?

Yes, most major brokerages offer fractional shares of BellRock Brands Inc. (DXBRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track DXBRF's earnings and financial reports?

BellRock Brands Inc. (DXBRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for DXBRF earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited due to the company's OTC listing.
  • Analyst coverage is minimal, resulting in a lack of consensus estimates.
  • The cannabis industry is subject to evolving regulations, which can impact the company's operations and financial performance.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover